Mitani Sangyo Co., Ltd.

Equities

8285

JP3886600000

Diversified Industrial Goods Wholesale

Market Closed - Japan Exchange 07:00:00 21/06/2024 BST 5-day change 1st Jan Change
359 JPY +1.99% Intraday chart for Mitani Sangyo Co., Ltd. 0.00% +6.85%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Mitani Sangyo Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2025 CI
Padayon Japan Inc announced that it has received funding from Mitani Sangyo Co., Ltd. and other investors CI
Mitani Sangyo Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2024 CI
Mitani Sangyo H1 Basic EPS Jumps to 14.19 Yen as Net Sales Rises 5.4% to 45.9 Billion Yen; Declares Interim Dividend of 4.50 Yen Per Share MT
Mitani Sangyo Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2024 CI
Mitani Sangyo's FY23 Profit Drops 33% MT
Mitani Sangyo Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2024 CI
Mitani Sangyo Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023 CI
Mitani Sangyo Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023 CI
Mitani Sangyo Co., Ltd.(TSE:8285) dropped from S&P Global BMI Index CI
Mitani Sangyo Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023 CI
Mitani Sangyo Co., Ltd. Announces Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2022 CI
Mitani Sangyo Co., Ltd. Announces Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2022 CI
Mitani Sangyo Co., Ltd. Provides Earnings Guidance for the Financial Results for the Year Ending March 31, 2022 CI
Mitani Sangyo Co., Ltd.(TSE:8285) added to S&P Global BMI Index CI
Mitani Sangyo Co., Ltd. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2021 CI
Mitani Sangyo Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2022 CI
Mitani Sangyo Co., Ltd. agreed to acquire remaining 49% stake in Active Pharma Co., Ltd. from Nichi-Iko Pharmaceutical Co., Ltd.. CI
Mitani Sangyo Co., Ltd. Announces Consolidated Earnings Results for the Year Ended March 31, 2021 CI
Mitani Sangyo Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2022 CI
Mitani Sangyo Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2020 CI
Mitani Sangyo Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2021 CI
JUNTEN BIO Co., Ltd. announced that it has received funding from Mitani Sangyo Co., Ltd. CI
HRBrain, Inc. announced that it has received ¥1.3 billion in funding from a group of investors CI
Mitani Sangyo Co., Ltd. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2020 CI
Chart Mitani Sangyo Co., Ltd.
More charts
MITANI SANGYO CO.,LTD. is a Japan-based company mainly engaged in the chemical-related business and others. The Company operates through six business segments. The Chemical segment provides hydrochloric, caustic soda, and other inorganic and organic chemicals, among others. The Air Conditioning Equipment segment offers air conditioning, plumbing sanitary and fire-fighting equipment, and others. The Information System segment provides system integration service, package software development, information infrastructure construction and other services. The Energy segment provides petroleum products, liquefied petroleum gas (LPG), fuel batteries for home use, solar power and wind power systems. The Resin and Electronics segment offers molds, synthetic resins and electronic components. The Building Equipment and Machinery segment provides housing facilities and system kitchen, and installment service. The Company is also involved in the building maintenance and management and others.
More about the company
  1. Stock Market
  2. Equities
  3. 8285 Stock
  4. News Mitani Sangyo Co., Ltd.
  5. Mitani Sangyo's Attributable Profit More Than Doubles in Fiscal Year Ended March